Laboratorios Farmaceúticos Rovi SA

Market Cap: Mid Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: ES0157261019

EUR

62.25

0.4 (0.65%)

Dec 12

MCE

Click here to see other stocks

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Faes Farma SA

Laboratorios Farmaceúticos Rovi SA

Almirall SA

Grifols SA

Laboratorio Reig Jofre SA

Labiana Health SA

Why is Laboratorios Farmaceúticos Rovi SA ?

With ROE of 23.47%, it has a Very Expensive valuation with a 5.31 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of -1.81%, its profits have fallen by -10.6%

Below par performance in long term as well as near term

Along with generating -1.81% returns in the last 1 year, the stock has also underperformed Spain IBEX 35 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Laboratorios Farmaceúticos Rovi SA for you?

Medium Risk, High Return

Absolute

Risk Adjusted

Volatility

Laboratorios Farmaceúticos Rovi SA

-1.5%

9.31

29.65%

Spain IBEX 35

43.26%

2.49

17.33%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

13.66%

EBIT Growth (5y)

24.84%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

0.12

Net Debt to Equity (avg)

0.13

Sales to Capital Employed (avg)

1.34

Tax Ratio

22.85%

Dividend Payout Ratio

28.30%

Pledged Shares

Institutional Holding

ROCE (avg)

36.67%

ROE (avg)

28.59%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

5.31

EV to EBIT

17.82

EV to EBITDA

15.23

EV to Capital Employed

4.77

EV to Sales

4.11

PEG Ratio

Dividend Yield

168.66%

ROCE (Latest)

26.76%

ROE (Latest)

23.47%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bullish

Bollinger Bands

Bullish

Mildly Bearish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is not working for Laboratorios Farmaceúticos Rovi SA

Operating Cash Flow - Annually

Lowest at EUR 114.35 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (EUR MM)

Cash and Cash Equivalents - Half Yearly

Lowest at EUR 25.32 MM

in the last six half yearly periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents (EUR MM)

Dividend Payout Ratio (DPR) - Annually

Lowest at 0.00 %

in the last five years

MOJO Watch

Company is distributing lower proportion of profits generated as dividend

DPR (%)